the effect of enalaprilat ( mk-422 ) , a newly synthesized , intravenous , nonsulfhydryl , angiotensin-converting enzyme inhibitor , was studied in seven patients with either severe or malignant hypertension .
C0014027
enalaprilat
C0020540
malignant hypertension